Citation Impact
Citing Papers
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
2008 Standout
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
2006 Standout
Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma
2005 Standout
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
2008 Standout
Reactive Oxygen Species in Inflammation and Tissue Injury
2013 Standout
In Vivo Electroporation Enhances the Immunogenicity of Hepatitis C Virus Nonstructural 3/4A DNA by Increased Local DNA Uptake, Protein Expression, Inflammation, and Infiltration of CD3+ T Cells
2007
Optimization of Skin Electroporation in Mice to Increase Tolerability of DNA Vaccine Delivery to Patients
2009
Treatment of kidney cancer
2009 StandoutNobel
Hallmarks of Cancer: The Next Generation
2011 Standout
Nucleoside-modified mRNA vaccination partially overcomes maternal antibody inhibition of de novo immune responses in mice
2020 StandoutNobel
The Regulation of Vascular Endothelial Growth Factor-induced Microvascular Permeability Requires Rac and Reactive Oxygen Species
2009
Improving the outcome of patients with castration-resistant prostate cancer through rational drug development
2006
EGFR Antagonists in Cancer Treatment
2008 Standout
Molecular imaging in drug development
2008 Standout
Cancer Invasion and the Microenvironment: Plasticity and Reciprocity
2011 Standout
Acromegaly
2006 Standout
Functional responses and in vivo anti-tumour activity of h7C10: A humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptors
2007
Involvement of Members of the Cadherin Superfamily in Cancer
2009
IGF-I mediated survival pathways in normal and malignant cells
2006
VEGF controls endothelial-cell permeability by promoting the β-arrestin-dependent endocytosis of VE-cadherin
2006
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
2006 Standout
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
2008 Standout
Insulin-like growth factors and neoplasia
2004
A Vast Repertoire of Dscam Binding Specificities Arises from Modular Interactions of Variable Ig Domains
2007 StandoutNobel
Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses
2010 StandoutNobel
IGF1 and IGFBP3 tagging polymorphisms are associated with circulating levels of IGF1, IGFBP3 and risk of breast cancer
2005
Ubiquitination of β-Arrestin Links Seven-transmembrane Receptor Endocytosis and ERK Activation
2007 StandoutNobel
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
2007 Standout
Bone marrow-derived endothelial progenitor cells are a major determinant of nascent tumor neovascularization
2007
Targeting the phosphoinositide 3-kinase pathway in cancer
2009 Standout
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
Adherens junctions in endothelial cells regulate vessel maintenance and angiogenesis
2007
Fibroblast growth factor signalling: from development to cancer
2010 Standout
Blocking the insulin-like growth factor-I receptor as a strategy for targeting cancer
2005
mTOR: from growth signal integration to cancer, diabetes and ageing
2010 Standout
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
2011 StandoutNobel
Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?
2008
Small-molecule inhibitors of protein–protein interactions: progressing towards the dream
2004 Standout
Molecular requirements for epithelial–mesenchymal transition during tumor progression
2005 Standout
Two-step adhesive binding by classical cadherins
2010
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB
2006 Standout
Electroporation enhances immune responses and protection induced by a bovine viral diarrhea virus DNA vaccine in newborn calves with maternal antibodies
2010
Type II Cadherin Ectodomain Structures: Implications for Classical Cadherin Specificity
2006
Dendritic Cells In Vivo: A Key Target for a New Vaccine Science
2008 StandoutNobel
Microenvironmental regulation of metastasis
2008 Standout
Survey of the year 2003 commercial optical biosensor literature
2004
The growth hormone receptor antagonist pegvisomant blocks both mammary gland development and MCF-7 breast cancer xenograft growth
2006
Pancreatic Cancer
2010 Standout
The Extracellular Architecture of Adherens Junctions Revealed by Crystal Structures of Type I Cadherins
2011 StandoutNobel
Tumor metastasis: mechanistic insights and clinical challenges
2006 Standout
Inhibition of mTORC1 leads to MAPK pathway activation through a PI3K-dependent feedback loop in human cancer
2008 Standout
Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation
2010
Microneedles for drug and vaccine delivery
2012 Standout
Monoclonal antibody antagonists of hypothalamic FGFR1 cause potent but reversible hypophagia and weight loss in rodents and monkeys
2006
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study
2011 Standout
Structure and Biochemistry of Cadherins and Catenins
2009
The PI3K Pathway in Human Disease
2017 Standout
Ras, PI(3)K and mTOR signalling controls tumour cell growth
2006 StandoutNature
Targeting PI3K signalling in cancer: opportunities, challenges and limitations
2009 Standout
Modes of resistance to anti-angiogenic therapy
2008 Standout
Tumor Angiogenesis
2008 Standout
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Insulin-Like Growth Factor 1 Receptor Targeted Therapeutics: Novel Compounds and Novel Treatment Strategies for Cancer Medicine
2008
Complementary Chimeric Isoforms Reveal Dscam1 Binding Specificity In Vivo
2012 StandoutNobel
IMC-A12, a Human IgG1 Monoclonal Antibody to the Insulin-Like Growth Factor I Receptor
2007
Newcastle Disease Virus Expressing a Dendritic Cell-Targeted HIV Gag Protein Induces a Potent Gag-Specific Immune Response in Mice
2010 StandoutNobel
Phase I, Pharmacokinetic and Pharmacodynamic Study of the Anti–Insulinlike Growth Factor Type 1 Receptor Monoclonal Antibody CP-751,871 in Patients With Multiple Myeloma
2008
Blockade of Paracrine Supply of Insulin-Like Growth Factors Using Neutralizing Antibodies Suppresses the Liver Metastasis of Human Colorectal Cancers
2005
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer
2007
Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies
2004
Contributions of Amino Acid Side Chains to the Kinetics and Thermodynamics of the Bivalent Binding of Protein L to Ig κ Light Chain
2004 StandoutNobel
Surface Plasmon Resonance Sensors for Detection of Chemical and Biological Species
2008 Standout
Disrupting insulin-like growth factor signaling as a potential cancer therapy
2007
Adhesion Molecules in the Nervous System: Structural Insights into Function and Diversity
2007
Dendritic cell targeted HIV gag protein vaccine provides help to a DNA vaccine including mobilization of protective CD8 + T cells
2010 StandoutNobel
Human Cytomegalovirus Glycoprotein B Nucleoside-Modified mRNA Vaccine Elicits Antibody Responses with Greater Durability and Breadth than MF59-Adjuvanted gB Protein Immunization
2020 StandoutNobel
Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody
2005
Vaccines: the Fourth Century
2009
Combination Therapy Enhances the Inhibition of Tumor Growth with the Fully Human Anti–Type 1 Insulin-Like Growth Factor Receptor Monoclonal Antibody CP-751,871
2005
Works of Rashed Abdullah being referenced
A fully human monoclonal antibody to the insulin-like growth factor I receptor blocks ligand-dependent signaling and inhibits human tumor growth in vivo.
2003
Identification of a transiently exposed VE-cadherin epitope that allows for specific targeting of an antibody to the tumor neovasculature
2005
Effect of Plasmid DNA Vaccine Design and In Vivo Electroporation on the Resulting Vaccine-Specific Immune Responses in Rhesus Macaques
2007